TherapeuticsMD reported $20K in Interest Expense on Debt for its fiscal quarter ending in September of 2023.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Cipla INR 170.3M 39M Jun/2026
Compugen USD 1.35M 399K Mar/2026
CSL USD 215M 111M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Pfizer USD 667M 4M Jun/2026
TherapeuticsMD USD 20K 25K Sep/2023